Samuel K. Kulp, D.V.M., Ph.D.
Affiliations: | 2001 | Veterinary Biosciences | Ohio State University, Columbus, Columbus, OH |
| 2002-2017 | Medicinal Chemistry | Ohio State University, Columbus, Columbus, OH | |
| 2018- | Pharmaceutics and Pharmaceutical Chemistry | Ohio State University, Columbus, Columbus, OH |
Google:
"Samuel Kulp"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Young C. Lin | grad student | 2001 | Ohio State | |
| (Characterization of a larval tapeworm excretory -secretory product that inhibits steroidogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liva SG, Tseng YC, Dauki AM, et al. (2020) Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. Embo Molecular Medicine. e9910 |
| Lu C, Yang D, Klement JD, et al. (2020) Abstract A32: The SUV39H1-H3K9me3 pathway represses cytotoxic T lymphocyte effector expression to confer colon carcinoma immune escape Cancer Immunology Research. 8 |
| Weng SC, Kashida Y, Kulp SK, et al. (2019) Retraction: Sensitizing Estrogen Receptor-negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor. Molecular Cancer Therapeutics. 18: 869 |
| Lu C, Yang D, Klement JD, et al. (2019) SUV39H1 represses the expression of cytotoxic T-lymphocyte effector genes to promote colon tumor immune evasion. Cancer Immunology Research |
| Murahari S, Jalkanen AL, Kulp SK, et al. (2017) Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis. Bmc Cancer. 17: 67 |
| Wu H, Yang M, Chu P, et al. (2017) Abstract 1360: Novel function of p21-activated kinase 3 (PAK3) in regulating Akt phosphorylation and pancreatic cancer stem cell phenotypes Cancer Research. 77: 1360-1360 |
| Chu PC, Kulp SK, Bekaii-Saab T, et al. (2016) Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer. Small Gtpases. 1-5 |
| Henderson SE, Ding LY, Mo X, et al. (2016) Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42. Neoplasia (New York, N.Y.). 18: 765-774 |
| Himmel LE, Lustberg MB, DeVries AC, et al. (2016) Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie |
| Hsu EC, Kulp SK, Huang HL, et al. (2016) Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer. Carcinogenesis |